J Watanabe

588 total citations
13 papers, 469 citations indexed

About

J Watanabe is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, J Watanabe has authored 13 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 2 papers in Oncology. Recurrent topics in J Watanabe's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). J Watanabe is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). J Watanabe collaborates with scholars based in Japan, United States and China. J Watanabe's co-authors include K Nishioka, Michael Houghton, Eiji Tanaka, Hiroshi Suzuki, George Kuo, Tatsuki Oda, Tetsuya Tsuji, Chieko Matsumoto, Takashi Oguchi and Hiroaki Okamoto and has published in prestigious journals such as Cancer, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

J Watanabe

13 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Watanabe Japan 10 349 341 56 34 32 13 469
Seyed Mohammad Jazayeri Iran 15 445 1.3× 531 1.6× 70 1.3× 28 0.8× 21 0.7× 80 724
Agoritsa Varaklioti Greece 12 361 1.0× 268 0.8× 27 0.5× 23 0.7× 6 0.2× 17 533
Yukio Itoh Japan 10 246 0.7× 268 0.8× 23 0.4× 8 0.2× 4 0.1× 20 509
Alex S. Hartlage United States 8 203 0.6× 191 0.6× 83 1.5× 22 0.6× 2 0.1× 11 342
H. Liermann Germany 6 187 0.5× 187 0.5× 130 2.3× 5 0.1× 3 0.1× 8 341
Stefanie Grethe Germany 7 485 1.4× 421 1.2× 24 0.4× 8 0.2× 4 0.1× 10 544
Jieting Huang China 12 213 0.6× 218 0.6× 45 0.8× 9 0.3× 5 0.2× 30 333
Wang Hj China 7 61 0.2× 190 0.6× 138 2.5× 35 1.0× 22 0.7× 12 484
Charles Harvey Australia 5 343 1.0× 271 0.8× 103 1.8× 2 0.1× 7 0.2× 6 467
L M Jarvis United Kingdom 9 793 2.3× 722 2.1× 11 0.2× 12 0.4× 3 0.1× 14 850

Countries citing papers authored by J Watanabe

Since Specialization
Citations

This map shows the geographic impact of J Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Watanabe more than expected).

Fields of papers citing papers by J Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Watanabe. The network helps show where J Watanabe may publish in the future.

Co-authorship network of co-authors of J Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of J Watanabe. A scholar is included among the top collaborators of J Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Watanabe. J Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chou, Sunwen & J Watanabe. (2024). Phenotypes of cytomegalovirus genetic variants encountered in a letermovir clinical trial illustrate the importance of genotyping validation. Antiviral Research. 228. 105935–105935. 1 indexed citations
2.
Chou, Sunwen & J Watanabe. (2023). Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. Antiviral Research. 222. 105792–105792. 10 indexed citations
3.
Gilman, Robert H., et al.. (1994). Rapid detection of Vibrio cholerae O1 in stools of Peruvian cholera patients by using monoclonal immunodiagnostic kits. Loyaza Cholera Working Group in Peru. Journal of Clinical Microbiology. 32(3). 856–857. 16 indexed citations
4.
Hiền, Bùi Thị Thu, Susumu Nakata, Toru Chosa, et al.. (1994). Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clinical and Diagnostic Laboratory Immunology. 1(4). 413–418. 28 indexed citations
5.
Watanabe, J, Chieko Matsumoto, K Nishioka, et al.. (1993). Predictive Value of Screening Tests for Persistent Hepatitis C Virus Infection Evidenced by Viraemia: Japanese Experience. Vox Sanguinis. 65(3). 199–203. 51 indexed citations
6.
Tanaka, Eiji, et al.. (1992). Prevalence of Antibody to Hepatitis C Virus in Japanese Schoolchildren: Comparison with Adult Blood Donors. American Journal of Tropical Medicine and Hygiene. 46(4). 460–464. 52 indexed citations
7.
Nishioka, K, et al.. (1992). [Incidence of hepatitis C in chronic liver diseases following tattooing].. PubMed. 133(15). 923–5. 5 indexed citations
8.
Sun, Yi, et al.. (1992). Preliminary report on seroepidemiology of HCV and HBV infection in northern China.. PubMed. 105(3). 209–11. 10 indexed citations
9.
Sun, Yu, et al.. (1991). Seroepidemiology of HCV and HBV infection in northern China. Gastroenterologia Japonica. 26(S3). 156–158. 17 indexed citations
10.
Yoshizawa, Hiroshi, Junko Tanaka, H. Iizuka, et al.. (1991). [Prevalence of the HCV associated markers among blood donors in Japan].. PubMed. 49(2). 357–65. 6 indexed citations
11.
Watanabe, J, Eiji Tanaka, Hiroshi Suzuki, et al.. (1991). A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 67(2). 429–433. 201 indexed citations
12.
Watanabe, J, et al.. (1990). The prevalence of anti‐HCV among Chinese voluntary blood donors in Taiwan. Transfusion. 30(5). 471–473. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026